Enanta Pharmaceuticals | Interessi Passivi Sul Debito

Interest Expense On Debt Cambiamento Data
Amgen USD 821M 62M 2023-12
Arrowhead Research USD 5.37M 105K 2023-12
Gilead Sciences USD 252M 20M 2023-12
Halozyme Therapeutics USD 5.22M 715K 2023-12
Incyte USD 804K 181K 2023-12
Insmed USD 21.57M 619K 2023-12
Ionis Pharmaceuticals USD 4.56M 355K 2023-12
Ligand Pharmaceuticals USD 131K 130K 2023-12
Neurocrine Biosciences USD 1.1M 200K 2023-09
Pfizer USD 689M 6M 2023-12
Roche Holding CHF 401M 53M 2023-06
Sarepta Therapeutics USD 5.23M 5K 2023-09
Vertex Pharmaceuticals USD 10.9M 300K 2023-09



Enanta Pharmaceuticals Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.